ctrl K

Price Alert

Lifecore Biomedical Inc. (LFCR)

NASDAQ: LFCR · Real-Time Price · USD

7.21

-0.21 (-2.83%)

At close: Aug 15, 2025, 10:21 AM

Lifecore Biomedical Income Statement

Financials in USD. Fiscal year is June - May.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 25, 2025	May 26, 2024	May 28, 2023	May 29, 2022	May 31, 2021
Revenue	128.87M	128.26M	103.27M	111.27M	100.87M
Cost of Revenue	88.57M	86.41M	75.98M	135.23M	462.69M
Gross Profit	40.3M	41.85M	27.98M	39.07M	38.94M
Operating Income	-38.72M	-8.84M	-21.8M	-11.79M	5.39M
Interest Income	n/a	n/a	68K	81K	48K
Pretax Income	-38.67M	9.51M	-63.93M	-20.69M	-29.79M
Net Income	-38.72M	12.01M	-99.56M	-116.72M	-32.66M
Selling & General & Admin	44.05M	40.46M	43.02M	42.63M	65.36M
Research & Development	8.26M	8.57M	8.24M	7.84M	10.22M
Other Expenses	n/a	1.66M	-1.48M	385K	-27.83M
Operating Expenses	52.3M	50.69M	49.78M	50.86M	47.76M
Interest Expense	21.84M	18.09M	17.65M	15.55M	8.93M
Selling & Marketing Expenses	n/a	n/a	5.1K	200K	100K
Cost & Expenses	140.87M	137.1M	125.06M	123.06M	109.7M
Income Tax Expense	43K	183K	308K	-5.21M	-6.35M
Shares Outstanding (Basic)	34.82M	30.47M	29.96M	29.47M	29.29M
Shares Outstanding (Diluted)	34.82M	36.66M	29.96M	29.47M	29.29M
EPS (Basic)	-1.27	0.39	-3.32	-3.97	-1.12
EPS (Diluted)	-1.27	0.33	-3.32	-3.97	-1.12
EBITDA	-38.72M	35.6M	-35.98M	14.23M	7.52M
EBIT	-16.84M	27.6M	-46.28M	-3.43M	-1.08M
Depreciation & Amortization	8.03M	8M	10.3M	17.66M	8.61M